Skip to main content

Navigation group

Type at least 3 characters
910 articles

Articles

Original Research

Accepted on 25 Nov 2024

Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses

in Virus and Host

  • LĂ­via Zignago Moreira Dos Santos
  • Camila Cristina Martini Rodrigues
  • Karina Takesaki Miyaji
  • Vanessa Infante
  • Camila de Melo Picone
  • Amanda Nazareth Lara
  • Hanna Kann
  • Carina Eklund
  • Joakim Dillner
  • Philippe Mayaud
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2024.1451308